The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Obesity and Cancer Mechanisms: Cancer Metabolism
Open accessAbstract
Obesity is a risk factor for cancer development and is associated with poor prognosis in multiple tumor types. The positive energy balance linked with obesity induces a variety of systemic changes including altered levels of insulin, insulin-like growth factor-1, leptin, adiponectin, steroid hormones, and cytokines. Each of these factors alters the nutritional milieu and has the potential to create an environment that favors tumor initiation and progression. Although the complete ramifications of obesity as it relates to cancer are still unclear, there is convincing evidence that reducing the magnitude of the systemic hormonal and inflammatory changes has significant clinical benefits. This review will examine the changes that occur in the obese state and review the biologic mechanisms that connect these changes to increased cancer risk. Understanding the metabolic changes that occur in obese individuals may also help to elucidate more effective treatment options for these patients when they develop cancer. Moving forward, targeted clinical trials examining the effects of behavioral modifications such as reduced carbohydrate intake, caloric restriction, structured exercise, and/or pharmacologic interventions such as the use of metformin, in obese populations may help to reduce their cancer risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationPrevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
Flegal, K. M., Carroll, M. D., Kit, B. K., & Ogden, C. L. (2012) · JAMA · doi:10.1001/jama.2012.39 · Cited by 5,385
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,680
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 1×
“away from oxidative phosphorylation for ATP production in favor of glycolysis.(11) Although this shift is in some ways paradoxical”
BackgroundAdipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Estrogen Carcinogenesis in Breast Cancer
Yager, J. D., & Davidson, N. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050776 · Cited by 1,862
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Mendoza, M. C., Er, E. E., & Blenis, J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.03.006 · Cited by 1,817
White, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,723
Bhaskaran, K., Douglas, I., Forbes, H., dos-Santos-Silva, I., Leon, D. A., & Smeeth, L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60892-8 · Cited by 1,707
Te Morenga, L., Mallard, S., & Mann, J. (2012) · BMJ · doi:10.1136/bmj.e7492 · Cited by 1,629
Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507
The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial
Neal, E. G., Chaffe, H., Schwartz, R. H., Lawson, M. S., Edwards, N., Fitzsimmons, G., Whitney, A., & Cross, J. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70092-9 · Cited by 1,224
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
Kaaks, R., Lukanova, A., & Kurzer, M. S. (2002) · PubMed · Cited by 1,183
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Pollak, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3215 · Cited by 1,116
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Li, N., Batzer, A., Daly, R., Yajnik, V., Skolnik, E., Chardin, P., Bar-Sagi, D., Margolis, B., & Schlessinger, J. (1993) · Nature · doi:10.1038/363085a0 · Cited by 952
Exercise for overweight or obesity
Shaw, K. A., Gennat, H. C., O'Rourke, P., & Del Mar, C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003817.pub3 · Cited by 950
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885
Adipose tissue and adipocytes support tumorigenesis and metastasis
Nieman, K. M., Romero, I. L., Van Houten, B., & Lengyel, E. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.02.010 · Cited by 749
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
Bendell, J. C., Rodon, J., Burris, H. A., de Jonge, M., Verweij, J., Birle, D., Demanse, D., De Buck, S. S., Ru, Q. C., Peters, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1360 · Cited by 684
Causes of death in cancer patients
Inagaki, J., Rodriguez, V., & Bodey, G. P. (1974) · Cancer · doi:10.1002/1097-0142(197402)33:2<568::aid-cncr2820330236>3.0.co;2-2 · Cited by 601
Garofalo, C., & Surmacz, E. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20472 · Cited by 588
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Wolk, A., Mantzoros, C. S., Andersson, S.-O., Bergstrom, R., Signorello, L. B., Lagiou, P., Adami, H.-O., & Trichopoulos, D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.911 · Cited by 575
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Li, J., Ho, G. Y. F., Xue, X., Anderson, G. L., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn415 · Cited by 563
Androgen receptor signaling in prostate cancer development and progression
Tindall, D., & Lonergan, P. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.83937 · Cited by 535
Activation of phosphatidylinositol 3-kinase by insulin.
Ruderman, N. B., Kapeller, R., White, M. F., & Cantley, L. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1411 · Cited by 524
Self-citationObesity and Breast Cancer: The Estrogen Connection
Cleary, M. P., & Grossmann, M. E. (2009) · Endocrinology · doi:10.1210/en.2009-0070 · Cited by 504
The role of protein in weight loss and maintenance
Leidy, H. J., Clifton, P. M., Astrup, A., Wycherley, T. P., Westerterp-Plantenga, M. S., Luscombe-Marsh, N. D., Woods, S. C., & Mattes, R. D. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.084038 · Cited by 475
Tumours with PI3K activation are resistant to dietary restriction
Kalaany, N. Y., & Sabatini, D. M. (2009) · Nature · doi:10.1038/nature07782 · Cited by 468
Insulin signaling meets mitochondria in metabolism
Cheng, Z., Tseng, Y., & White, M. F. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.06.005 · Cited by 449
Simon, M. (1993) · Cell · doi:10.1016/0092-8674(93)90169-q · Cited by 448
A high-fat, ketogenic diet induces a unique metabolic state in mice
Kennedy, A. R., Pissios, P., Otu, H., Xue, B., Asakura, K., Furukawa, N., Marino, F. E., Liu, F.-F., Kahn, B. B., Libermann, T. A., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00717.2006 · Cited by 420
Law, J. H., Habibi, G., Hu, K., Masoudi, H., Wang, M. Y. C., Stratford, A. L., Park, E., Gee, J. M. W., Finlay, P., Jones, H. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2755 · Cited by 401
Shaham, O., Wei, R., Wang, T. J., Ricciardi, C., Lewis, G. D., Vasan, R. S., Carr, S. A., Thadhani, R., Gerszten, R. E., & Mootha, V. K. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.50 · Cited by 399
Nomura, S., Sakamaki, S., Hongu, M., Kawanishi, E., Koga, Y., Sakamoto, T., Yamamoto, Y., Ueta, K., Kimata, H., Nakayama, K., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100332n · Cited by 385
The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications
Moschos, S. J., & Mantzoros, C. S. (2002) · Oncology · doi:10.1159/000066230 · Cited by 371
Kordes, S., Pollak, M. N., Zwinderman, A. H., Mathôt, R. A., Weterman, M. J., Beeker, A., Punt, C. J., Richel, D. J., & Wilmink, J. W. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00027-3 · Cited by 361
Minireview: IGF, Insulin, and Cancer
Gallagher, E. J., & LeRoith, D. (2011) · Endocrinology · doi:10.1210/en.2011-0231 · Cited by 349
Elevated insulin receptor content in human breast cancer
Papa, V, Pezzino, V, Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., Vannelli, G. B., Brand, R., Goldfine, I. D., & Vigneri, R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114868 · Cited by 338
SGLT inhibitors in management of diabetes
Tahrani, A. A., Barnett, A. H., & Bailey, C. J. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70050-0 · Cited by 332
Higurashi, T., Hosono, K., Takahashi, H., Komiya, Y., Umezawa, S., Sakai, E., Uchiyama, T., Taniguchi, L., Hata, Y., Uchiyama, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00565-3 · Cited by 331
Bedard, P. L., Tabernero, J., Janku, F., Wainberg, Z. A., Paz-Ares, L., Vansteenkiste, J., Van Cutsem, E., Pérez-García, J., Stathis, A., Britten, C. D., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1814 · Cited by 324
Quantitative Mass Spectrometry Identifies Insulin Signaling Targets in C. elegans
Dong, M.-Q., Venable, J. D., Au, N., Xu, T., Park, S. K., Cociorva, D., Johnson, J. R., Dillin, A., & Yates, J. R. (2007) · Science · doi:10.1126/science.1139952 · Cited by 312
Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
Schlaepfer, I. R., Rider, L., Rodrigues, L. U., Gijón, M. A., Pac, C. T., Romero, L., Cimic, A., Sirintrapun, S. J., Glodé, L. M., Eckel, R. H., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0183 · Cited by 304
Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact
Prado, C. M., Cushen, S. J., Orsso, C. E., & Ryan, A. M. (2016) · Proceedings of the Nutrition Society · doi:10.1017/s0029665115004279 · Cited by 300
Livingstone, C. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0231 · Cited by 296
Hadad, S., Iwamoto, T., Jordan, L., Purdie, C., Bray, S., Baker, L., Jellema, G., Deharo, S., Hardie, D. G., Pusztai, L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1612-1 · Cited by 293
ERGO: A pilot study of ketogenic diet in recurrent glioblastoma
RIEGER, J., BÄHR, O., MAURER, G. D., HATTINGEN, E., FRANZ, K., BRUCKER, D., WALENTA, S., KÄMMERER, U., COY, J. F., WELLER, M., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2382 · Cited by 287
Housa, D., Housová, J., Vernerová, Z., & Haluzík, M. (2006) · Physiological Research · doi:10.33549/physiolres.930848 · Cited by 263
Sos, M. L., Fischer, S., Ullrich, R., Peifer, M., Heuckmann, J. M., Koker, M., Heynck, S., Stückrath, I., Weiss, J., Fischer, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907325106 · Cited by 254
Energy Balance, Host-Related Factors, and Cancer Progression
Hursting, S. D., & Berger, N. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.27.9935 · Cited by 252
Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
Bonanni, B., Puntoni, M., Cazzaniga, M., Pruneri, G., Serrano, D., Guerrieri-Gonzaga, A., Gennari, A., Trabacca, M. S., Galimberti, V., Veronesi, P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.3769 · Cited by 244
Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
Pollak, M. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0175 · Cited by 240
Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
Niraula, S., Dowling, R. J. O., Ennis, M., Chang, M. C., Done, S. J., Hood, N., Escallon, J., Leong, W. L., McCready, D. R., Reedijk, M., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2223-1 · Cited by 238
Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme
Champ, C. E., Palmer, J. D., Volek, J. S., Werner-Wasik, M., Andrews, D. W., Evans, J. J., Glass, J., Kim, L., & Shi, W. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1362-0 · Cited by 224
Non-Islet Cell Tumour-Induced Hypoglycaemia: A Review of the Literature Including Two New Cases
de Groot, J. W. B., Rikhof, B., van Doorn, J., Bilo, H. J. G., Alleman, M. A., Honkoop, A. H., & van der Graaf, W. T. A. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0161 · Cited by 222
Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancer
Hammarsten, J., & Högstedt, B. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.003 · Cited by 214
Saxena, N. K., Vertino, P. M., Anania, F. A., & Sharma, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609798200 · Cited by 203
Fine, E. J., Segal-Isaacson, C. J., Feinman, R. D., Herszkopf, S., Romano, M. C., Tomuta, N., Bontempo, A. F., Negassa, A., & Sparano, J. A. (2012) · Nutrition · doi:10.1016/j.nut.2012.05.001 · Cited by 200
Effects of adiponectin on breast cancer cell growth and signaling
Grossmann, M. E., Nkhata, K. J., Mizuno, N. K., Ray, A., & Cleary, M. P. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604166 · Cited by 198
Adiponectin as a growth inhibitor in prostate cancer cells
Bub, J. D., Miyazaki, T., & Iwamoto, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.103 · Cited by 198
Prostate Cancer Cell-Adipocyte Interaction
Onuma, M., Bub, J. D., Rummel, T. L., & Iwamoto, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304984200 · Cited by 189
Obesity, Energy Balance, and Cancer: New Opportunities for Prevention
Hursting, S. D., DiGiovanni, J., Dannenberg, A. J., Azrad, M., LeRoith, D., Demark-Wahnefried, W., Kakarala, M., Brodie, A., & Berger, N. A. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0140 · Cited by 181
Iams, W. T., & Lovly, C. M. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2518 · Cited by 179
Does intentional weight loss reduce cancer risk?
Byers, T., & Sedjo, R. L. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01464.x · Cited by 177
Reni, M., Dugnani, E., Cereda, S., Belli, C., Balzano, G., Nicoletti, R., Liberati, D., Pasquale, V., Scavini, M., Maggiora, P., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1722 · Cited by 170
Allan, C. A., & McLachlan, R. I. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283398ee2 · Cited by 168
Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis
Hernandez, A. V., Pasupuleti, V., Benites-Zapata, V. A., Thota, P., Deshpande, A., & Perez-Lopez, F. R. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.08.031 · Cited by 167
Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer
Antoun, S., Borget, I., & Lanoy, É. (2013) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000011 · Cited by 154
Schuler, K., Rambally, B. S., DiFurio, M. J., Sampey, B. P., Gehrig, P. A., Makowski, L., & Bae-Jump, V. L. (2014) · Cancer Medicine · doi:10.1002/cam4.353 · Cited by 142
Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32
Goodwin, P. J., Parulekar, W. R., Gelmon, K. A., Shepherd, L. E., Ligibel, J. A., Hershman, D. L., Rastogi, P., Mayer, I. A., Hobday, T. J., Lemieux, J., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv006 · Cited by 135
Li, C., Gasser, J. A., Zhao, J., Yang, B., Li, F., & Zhao, A. Z. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0065 · Cited by 129
Guo, J. Y., & White, E. (2013) · Autophagy · doi:10.4161/auto.26123 · Cited by 128
Stromal Estrogen Receptor-α Promotes Tumor Growth by Normalizing an Increased Angiogenesis
Péqueux, C., Raymond‐Letron, I., Blacher, S., Boudou, F., Adlanmérini, M., Fouque, M.-J., Rochaix, P., Noël, A., Foidart, J.-M., Krust, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3768 · Cited by 126
Interaction between Adiponectin and Leptin Influences the Risk of Colorectal Adenoma
Yamaji, T., Iwasaki, M., Sasazuki, S., & Tsugane, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0178 · Cited by 120
Douris, N., Melman, T., Pecherer, J. M., Pissios, P., Flier, J. S., Cantley, L. C., Locasale, J. W., & Maratos–Flier, E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.07.009 · Cited by 118
Self-citationDowling, R. J., Niraula, S., Chang, M. C., Done, S. J., Ennis, M., McCready, D. R., Leong, W. L., Escallon, J. M., Reedijk, M., Goodwin, P. J., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0540-0 · Cited by 117
Hudis, C. A., Swanton, C., Janjigian, Y. Y., Lee, R., Sutherland, S., Lehman, R. J., Chandarlapaty, S., Hamilton, N., Gajria, D., Knowles, J., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3577 · Cited by 107
Fazolini, N. P. B., Cruz, A. L. S., Werneck, M. B. F., Viola, J. P. B., Maya‐Monteiro, C. M., & Bozza, P. T. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1041684 · Cited by 105
Laskov, I., Drudi, L. M., Beauchamp, M.-C., Yasmeen, A., Ferenczy, A. S., Pollak, M., & Gotlieb, W. H. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.06.014 · Cited by 104
Fenton, J. I., Hursting, S. D., Perkins, S. N., & Hord, N. G. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl018 · Cited by 102
Allen, N. E., Key, T. J., Appleby, P. N., Travis, R. C., Roddam, A., Rinaldi, S., Egevad, L., Rohrmann, S., Linseisen, J., Pischon, T., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-1062 · Cited by 100
Hadad, S. M., Coates, P. J., Jordan, L. B., Dowling, R. J. O., Chang, M. C., Done, S. J., Purdie, C. A., Goodwin, P. J., Stambolic, V., Moulder-Thompson, S. L., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3307-5 · Cited by 99
Ferguson, R. D., Novosyadlyy, R., Fierz, Y., Alikhani, N., Sun, H., Yakar, S., & LeRoith, D. (2012) · Breast Cancer Research · doi:10.1186/bcr3089 · Cited by 99
Expression of insulin-like growth factor 2 in mesenchymal neoplasms
Steigen, S. E., Schaeffer, D. F., West, R. B., & Nielsen, T. O. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.48 · Cited by 96
Jones, R. L., Kim, E. S., Nava-Parada, P., Alam, S. M., Johnson, F. M., Stephens, A. W., Simantov, R., Poondru, S., Gedrich, R., Lippman, S. M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0265 · Cited by 96
Insulin receptor expression and clinical outcome in node-negative breast cancer.
Mathieu, M. C., Clark, G. M., Allred, D. C., Goldfine, I. D., & Vigneri, R. (1997) · PubMed · Cited by 91
Gallagher, E. J., Fierz, Y., Vijayakumar, A., Haddad, N., Yakar, S., & LeRoith, D. (2011) · Oncogene · doi:10.1038/onc.2011.495 · Cited by 90
Wink, K. C. J., Belderbos, J. S. A., Dieleman, E. M. T., Rossi, M. M. G., Rasch, C. R. N., Damhuis, R. A. M., Houben, R. M. A., & Troost, E. G. C. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.01.012 · Cited by 84
Measuring the biological effect of presurgical metformin treatment in endometrial cancer
Sivalingam, V. N., Kitson, S., McVey, R. J., Roberts, C., Pemberton, P. W., Gilmour, K., Ali, S., Renehan, A. G., Kitchener, H. C., & Crosbie, E. J. (2016) · British Journal of Cancer · doi:10.1038/bjc.2015.453 · Cited by 83
Miranda, V. D. C., Braghiroli, M. I., Faria, L. D. B. B., Bariani, G. M., Alex, A. K., Neto, J. E. B., Capareli, F. C., Sabbaga, J., dos Santos, J. F. L., Hoff, P. M., et al. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.04.011 · Cited by 80
Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer
Kalinsky, K. M., Crew, K. D., Refice, S., Xiao, T., Wang, A., Feldman, S. M., Taback, B., Ahmad, A., Cremers, S., Hibshoosh, H. H., et al. (2014) · Cancer Investigation · doi:10.3109/07357907.2014.889706 · Cited by 79
Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis
Yoon, Y. S., Keum, N., Zhang, X., Cho, E., & Giovannucci, E. L. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.013 · Cited by 73
Rodríguez‐Enríquez, S., Hernández‐Esquivel, L., Marín‐Hernández, Á., Hafidi, M. E., Gallardo‐Pérez, J. C., Hernández‐Reséndiz, I., Rodríguez‐Zavala, J. S., Pacheco-Velázquez, S. C., & Moreno‐Sánchez, R. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.06.010 · Cited by 72
Vujic, I., Sanlorenzo, M., Posch, C., Esteve‐Puig, R., Yen, A., Kwong, A., Tsumura, A., Murphy, R. M., Rappersberger, K., & Ortiz‐Urda, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2824 · Cited by 72
Pierre‐Eugène, C., Pagésy, P., Nguyen, T. T., Neuillé, M., Tschank, G., Tennagels, N., Hampe, C., & Issad, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041992 · Cited by 72
Highly specific role of the insulin receptor in breast cancer progression
Rostoker, R., Abelson, S., Bitton-Worms, K., Genkin, I., Ben-Shmuel, S., Dakwar, M., Orr, Z. S., Caspi, A., Tzukerman, M., & LeRoith, D. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0490 · Cited by 72
Salehi, M., Ferenczi, A., & Zumoff, B. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-861374 · Cited by 70
Alvino, C. L., Ong, S. C., McNeil, K. A., Delaine, C. A., Booker, G. W., Wallace, J. C., & Forbes, B. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027488 · Cited by 70
Chemoprevention Meets Glucose Control
Engelman, J. A., & Cantley, L. C. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0178 · Cited by 59
Self-citationMetformin and erlotinib synergize to inhibit basal breast cancer
Lau, Y.-K. I., Du, X., Rayannavar, V., Hopkins, B. D., Shaw, J. M., Bessler, E., Thomas, T. A., Pires, M. M., Keniry, M. E., Parsons, R. E., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2391 · Cited by 58
Self-citationAltered Expression of Insulin Receptor Isoforms in Breast Cancer
Huang, J., Morehouse, C., Streicher, K. L., Higgs, B. W., Gao, J., Czapiga, M., Boutrin, A., Zhu, W., Brohawn, P. Z., Chang, Y. S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026177 · Cited by 56
Coppola, G., Klepper, J., Ammendola, E., Fiorillo, M., della Corte, R., Capano, G., & Pascotto, A. (2006) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2006.03.001 · Cited by 56
Chak, A., Buttar, N. S., Foster, N. R., Seisler, D. K., Marcon, N. E., Schoen, R. E., Cruz-Correa, M. R., Falk, G. W., Sharma, P., Hur, C., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.040 · Cited by 50
Braghiroli, M. I., Ferrari, A. C. R. D. C., Pfiffer, T., Alex, A. K., Nebuloni, D. R., Cagnacci, A. Q. C., Capareli, F. C., Leite, L. A. S., Lobo, J., Hoff, P. M., et al. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.563 · Cited by 48
Jiang, W., Zhu, Z., Bhatia, N., Agarwal, R., & Thompson, H. J. (2002) · PubMed · Cited by 47
Jeyaratnaganthan, N., Højlund, K., Kroustrup, J. P., Larsen, J. F., Bjerre, M., Levin, K., Beck‐Nielsen, H., Frago, S., Hassan, A. B., Flyvbjerg, A., et al. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.12.005 · Cited by 44
Energy balance modulates colon tumor growth: Interactive roles of insulin and estrogen
Rondini, E. A., Harvey, A. E., Steibel, J. P., Hursting, S. D., & Fenton, J. I. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20720 · Cited by 41
Jiang, L., Zhu, W., Streicher, K. L., Morehouse, C., Brohawn, P. Z., Ge, X., Dong, Z., Yin, X., Zhu, G., Gu, Y., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-131 · Cited by 37
IGF‐I, IGF binding protein‐3 and breast cancer risk: Comparison of 3 meta‐analyses
Renehan, A. G., Egger, M., Minder, C. E., O’Dwyer, S., Shalet, S. M., & Zwahlen, M. (2005) · International Journal of Cancer · doi:10.1002/ijc.20975 · Cited by 36
Mechanisms linking obesity to altered metabolism in mice colon carcinogenesis
Nimri, L., Saadi, J., Peri, I., Yehuda‐Shnaidman, E., & Schwartz, B. (2015) · Oncotarget · doi:10.18632/oncotarget.5561 · Cited by 36
Flannery, C. A., Saleh, F., Choe, G. H., Selen, D. J., Kodaman, P. H., Kliman, H. J., Wood, T. L., & Taylor, H. S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1795 · Cited by 36
Metformin and Gynecologic Cancers
Stine, J. E., & Bae-Jump, V. L. (2014) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000092 · Cited by 33
DeCensi, A., Puntoni, M., Guerrieri‐Gonzaga, A., Cazzaniga, M., Serrano, D., Lazzeroni, M., Vingiani, A., Gentilini, O., Petrera, M., Viale, G., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0048 · Cited by 31
Metformin: risk-benefit profile with a focus on cancer
Provinciali, N., Lazzeroni, M., Cazzaniga, M., Gorlero, F., Dunn, B. K., & DeCensi, A. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1084289 · Cited by 21
Kalinsky, K. M., Zheng, T., Hibshoosh, H. H., Du, X., Mundi, P. S., Yang, J., Refice, S., Feldman, S. M., Taback, B., Connolly, E. P., et al. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1521-1 · Cited by 14
Joerger, M., van Schaik, R. H. N., Becker, M. L., Hayoz, S., Pollak, M., Cathomas, R. L., Winterhalder, R., Gillessen, S., & Rothermundt, C. A. (2015) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2015.8 · Cited by 13
Cited by
The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
Self-citationObesity and cancer risk: Emerging biological mechanisms and perspectives
Avgerinos, K. I., Spyrou, N., Mantzoros, C. S., & Dalamaga, M. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.001 · Cited by 1,567
International patterns and trends in endometrial cancer incidence, 1978-2013.
Lortet-Tieulent, J., Ferlay, J., Bray, F., & Jemal, A. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx214 · Cited by 760
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
Hopkins, B. D., Pauli, C., Du, X., Wang, D. G., Li, X., Wu, D., Amadiume, S. C., Goncalves, M. D., Hodakoski, C., Lundquist, M. R., et al. (2018) · Nature · doi:10.1038/s41586-018-0343-4 · Cited by 706
Self-citationMakker, V., MacKay, H., Ray-Coquard, I., Levine, D. A., Westin, S. N., Aoki, D., & Oaknin, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00324-8 · Cited by 674
Metadata
- Authors
- Hopkins, B. D., Goncalves, M. D., & Cantley, L. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2016-12-10
- Volume
- 34
- Issue
- 35
- Pages
- 4277-4283
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2552631557
- Cited by
- 414
- References
- 126
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.